UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060013
Receipt number R000068638
Scientific Title Survey on Sensitive Awareness
Date of disclosure of the study information 2026/01/19
Last modified on 2025/12/08 13:36:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on Sensitive Awareness

Acronym

Survey on Sensitive Awareness

Scientific Title

Survey on Sensitive Awareness

Scientific Title:Acronym

Survey on Sensitive Awareness

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the actual state of daily fluctuations in sensitivity awareness

Basic objectives2

Others

Basic objectives -Others

The relationship between sensitive awareness and other items

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The relationship between sensitive awareness and other items

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

1. Japanese women aged 30 to 49
2. Individuals capable of collecting sebum samples each morning before washing their face

Key exclusion criteria

1. Person who has abnormalities on the skin of the test site.
2. Person with attend medical institutions at all times.
3. Person who use the drug at all times.
4. Person with severe atopic dermatitis or hay fever.
5. Person judged by the person in charge of the examination to be inappropriate.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Tojo

Organization

Kao Corporation

Division name

Skin Care Products Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7286

Email

tojo.kaori@kao.com


Public contact

Name of contact person

1st name Noriko
Middle name
Last name Haketa

Organization

Kao Corporation

Division name

Skin Care Products Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7286

Homepage URL


Email

haketa.noriko@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 09 Month 15 Day

Date of IRB

2025 Year 10 Month 20 Day

Anticipated trial start date

2026 Year 01 Month 19 Day

Last follow-up date

2026 Year 02 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The relationship between sensitive awareness and other items


Management information

Registered date

2025 Year 12 Month 08 Day

Last modified on

2025 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068638